Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
Volume: 44, Issue: 4, Pages: 370 - 379
Published: Jan 1, 2019
Abstract
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Skrzypczyk P, PrzychodzieÅ J, Mizerska-Wasiak M, et al. Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases. Central European Journal of Immunology. 2019;44(4):370-379. doi:10.5114/ceji.2019.92788. APA Skrzypczyk, P., PrzychodzieÅ, J., Mizerska-Wasiak, M., Kuźma-Mroczkowska, E., Stelmaszczyk-Emmel, A., &...
Paper Details
Title
Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
Published Date
Jan 1, 2019
Volume
44
Issue
4
Pages
370 - 379
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History